Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

$HIMSPress releaseSep 2, 2026, 8:12 PM ETRead the release

Kahn Swick & Foti, LLC is reminding investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities fraud class action against Hims & Hers Health pending in the Northern District of California (Velanki v. Hims & Hers Health, Inc., 26-cv-09313). The class period covers purchasers of HIMS securities between August 4, 2025 and July 29, 2026.

Key figures

Class period
August 4, 2025 to July 29, 2026
Stock drop usd
4.32
Stock drop percent
14.73%
Close price 2026 07 29
25
Lead plaintiff deadline
November 2, 2026

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    HIMS: Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC — AI Analysis | Signal8